A randomized double‐blind, placebo‐controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA‐230 during experimental human endotoxaemia - Concepedia

Concepedia

Publication | Open Access

A randomized double‐blind, placebo‐controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA‐230 during experimental human endotoxaemia

DOI Full Paper Access

12

Citations

30

References

2019

Year

Roger van Groenendael, Matthijs Kox, Guus P. Leijte, Bouke Koeneman, Jelle Gerretsen, Lucas van Eijk, Peter Pickkers

British Journal of Clinical Pharmacology

Abstract

Administration of EA-230 is safe and results in attenuation of the systemic inflammatory response in humans.

References

	Year	Citations

Page 1